Biogen Inc
Company Profile
Business description
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.
Contact
225 Binney Street
Cambridge MA 02142
USAT: +1 617 679-2000
E: IR@biogen.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
7,570
Biogen Inc News & Analysis
stocks
24 stocks for 2030
video
3 top picks in global healthcare
video
4 healthcare stocks attractive on valuation and ESG risk
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,883.50 | 46.10 | 0.59% |
| CAC 40 | 8,088.24 | 71.59 | 0.89% |
| DAX 40 | 18,161.01 | 243.73 | 1.36% |
| Dow JONES (US) | 38,239.66 | 153.86 | 0.40% |
| FTSE 100 | 8,139.83 | 60.97 | 0.75% |
| HKSE | 17,651.15 | 366.61 | 2.12% |
| NASDAQ | 15,927.90 | 316.14 | 2.03% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,834.58 | 29.49 | 0.25% |
| S&P 500 | 5,099.96 | 51.54 | 1.02% |
| S&P/ASX 200 | 7,618.70 | 42.80 | 0.56% |
| SSE Composite Index | 3,088.64 | 35.74 | 1.17% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.08 | 0.00 | 3.80% |
| Jupiter Mines Ltd JMS | 0.31 | 0.01 | 2.50% |
| BrainChip Holdings Ltd BRN | 0.29 | 0.01 | -4.10% |
| Droneshield Ltd DRO | 0.82 | 0.02 | -1.81% |
| Pilbara Minerals Ltd PLS | 3.88 | 0.08 | 2.11% |
| Mesoblast Ltd MSB | 0.99 | 0.06 | 5.91% |
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.37% |
| Zip Co Ltd ZIP | 1.21 | 0.06 | 4.76% |
| The Star Entertainment Group Ltd SGR | 0.40 | 0.01 | 1.28% |